USPTO serial 79403935
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eleanor M. Yost
Eleanor M. Yost Carlton Fields, P.A.P.O. Box 3239Tampa, FL 33601United States| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Statistical data processing services, namely the compilation of statistics; data collection services, in particular statistics for the medical and biomedical fields; statistical recording and processing services, in particular in the medical, biomedical, and cosmetic fields; statistical collection and processing services for clinical trials for the cosmetics, pharmaceutical, and food industries; business consultancy in health care. | ACTIVE | — |
| 042 | Pharmaceutical research and development services; medical and pharmacological research services in the nature of laboratory research in the field of pharmaceuticals; scientific laboratory services, namely, laboratory analytical and quality assurance testing of pharmaceutical products; pharmaceutical product evaluation; analytical scientific laboratory services for pharmaceuticals; technological analysis services, namely, assays and biological tests of pharmaceutical preparations, sterility testing of pharmaceutical preparations, stability testing of pharmaceutical preparations, operational hygiene monitoring testing of pharmaceutical preparations, testing of physical and physiochemical properties of pharmaceutical preparations, limit testing of pharmaceutical preparations, dissolution and particle analysis of pharmaceutical preparations, pH testing of pharmaceutical preparations, density testing of pharmaceutical preparations, liquid and gas chromatography testing of pharmaceutical preparations, radioactivity testing of pharmaceutical preparations, mass spectrometry testing of pharmaceutical preparations; providing information about industrial analysis and research services in the field of pharmaceuticals; chemistry, biochemistry, microbiology and physics services namely, laboratory testing in the field of pharmaceuticals; providing technical and natural science expertise and research namely, technical consulting services in the field of developing pharmaceutical testing protocols and studies; development of analytical methods, namely, creating research and clinical tests for others relating to pharmaceutical products; consultancy relating to application technology and natural sciences in the nature of consulting services in the field of pharmaceutical research and development; microbiological testing of goods in the nature of pharmaceuticals; examinations of medicines and pharmaceutical raw materials, in particular radiopharmaceuticals, namely, sterility testing of radioactive pharmaceutical products, scientific analysis of precursors for radiopharmaceuticals, impurity testing of radiopharmaceuticals, testing for residual solvents for radiopharmaceuticals, and laboratory analysis of elemental impurities for radiopharmaceuticals; laboratory research services relating to pharmaceuticals; quality checking and testing of pharmaceutical products and preparations, namely, sterility testing, operational hygiene monitoring, dissolution and particle analysis, leachables/extractables studies, elemental analysis, gas chromatography, stability testing, and high-performance liquid chromatography (HPLC), all the foregoing for pharmaceutical products and preparations; materials testing and analyzing; testing of chemicals; working on and evaluation of chemical analyses; conducting sampling and analysis services to check for contamination of pharmaceutical preparations; microbiological testing, namely, microbiological examination of pharmaceutical products, microbial enumeration testing of pharmaceutical products, testing for test for bacterial endotoxins; clinical expertise, namely, technical consulting in the field of pharmaceutical studies; chemical analysis services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biological safety testing of pharmaceuticals and cosmetics; scientific laboratory testing in the fields of toxicology, clinical microbiology and intestinal microecology; Scientific research in the nature of conducting clinical trials for others; Laboratory services for the production of pharmaceuticals in the nature of research and development of new pharmaceutical products and testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals; Consulting services in the field of pharmaceutical research and development. | ACTIVE | — |
| 044 | Medical services; pharmaceutical advice; consultancy in the field of human hygiene and beauty care; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; consultancy in connection with the aforesaid services. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 8, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 8, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 19, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 4, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 4, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 30, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 30, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 30, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 12, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 12, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 7, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 7, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 7, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 29, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 26, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 5, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |